More importantly, disturbances in intracellular signaling pathways related to the pathological expression of EMT mesenchymal biomarkers (TGF-β1, SMAD3 and ILK) may have clinical significance in the diagnostic and therapeutic aspects of endometriosis. This evidence concerns the gene SMAD3 and endometriosis.